Database Entry Point
max planck institut
informatik
mpii logo Minerva of the Max Planck Society
 

MPI-INF D3 Publications, generated: 2:52, 21 October 2019

Search the publication database

  . Return

Your search returned the following 18 documents:

  1. Alejandro Pironti, Nico Pfeifer, Rolf Kaiser, Hauke Walter, and Thomas Lengauer
    Accurate prediction of drug-exposure without using established drug-resistance mutations
    In: Antiviral Therapy, Berlin, Germany, 2014, A75 p.
  2. Alejandro Pironti, Nico Pfeifer, and Thomas Lengauer
    Accurate prediction of drug-exposure without using established drug-resistance mutations
    In: Antiviral Therapy, Berlin, Germany, 2014, A75 p.
  3. Alejandro Pironti, Nico Pfeifer, and Thomas Lengauer
    Improved HIV-1 drug-exposure reconstruction with linear support vector machines
    In: Reviews in Antiviral Therapy & Infectious Diseases, Barcelona, Spain, 2014, 67 p.
  4. Alejandro Pironti, Nico Pfeifer, Rolf Kaiser, Hauke Walter, and Thomas Lengauer
    Improved HIV-1 drug-exposure reconstruction with linear support vector machines
    In: Reviews in Antiviral Therapy & Infectious Diseases, Barcelona, Spain, 2014, 67 p.
  5. Alejandro Pironti, Nico Pfeifer, Rolf Kaiser, Hauke Walter, and Thomas Lengauer
    Improved therapy-success prediction with GSS estimated from clinical HIV-1 sequences
    In: Abstract Supplement of the HIV Drug Therapy Glasgow Congress 2014, Glasgow, UK, 2014, 155 p.
  6. Alejandro Pironti, Saleta Sierra, Rolf Kaiser, Thomas Lengauer, and Nico Pfeifer
    Simulation of Sanger-sequencing errors in the context of genotypic tropism determination
    In: Antiviral Therapy, Berlin, Germany, 2014, A81 p.
  7. Alejandro Pironti, Thomas Lengauer, and Nico Pfeifer
    Simulation of Sanger-sequencing errors in the context of genotypic tropism determination
    In: Antiviral Therapy, Berlin, Germany, 2014, A81 p.
  8. Alejandro Pironti, Thomas Lengauer, and Nico Pfeifer
    Effects of sequencing errors on geno2pheno[coreceptor] predictions
    In: Abstract Book 11th European Meeting on HIV & Hepatitis, Rome, Italy, 2013, 23-24
  9. Alejandro Pironti
    HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure
    Infection, Genetics and Evolution 19: 349–360 p., 2013
  10. Alejandro Pironti, Thomas Lengauer, and Nico Pfeifer
    In silico analysis of the effects of sequencing errors on geno2pheno[coreceptor]
    In: Abstract Book of the International Workshop on HIV&Hepatitis Virus, Toronto, Canada, 2013, A142 p.
  11. Alejandro Pironti, Thomas Lengauer, Rolf Kaiser, Eugen Schülter, and Jens Verheyen
    Characterization of HIV-1 Gag Subtype C
    In: Abstract Book. 9th Workshop on HIV \& Hepatitis Treatment Strategies \& Antiviral Drug Resistance, Barcelona, Spain, 2012, 40-41
  12. Eugen Schuelter, Nadine Lübcke, Björn Jensen, Maurizio Zazzi, Anders Sönnerborg, Thomas Lengauer, Francesca Incardona, Richardo Camacho, J Schmit, Bonaventura Clotet, Rolf Kaiser, and Alejandro Pironti
    Etravirine in protease inhibitor-free antiretroviral combination therapies
    In: Journal of the International AIDS Society, Glasgow, UK, 2012, 155-156
  13. Martin Obermeier, Alejandro Pironti, Thomas Berg, Patrick Braun, Martin Däumer, Josef Eberle, Robert Ehret, Rolf Kaiser, Niels Kleinkauf, Klaus Korn, Claudia Kücherer, Harm Müller, Christian Noah, Martin Stürmer, Alexander Thielen, Eva Wolf, and Hauke Walter
    HIV-GRADE: A Publicly Available, Rules-Based Drug Resistance Interpretation Algorithm Integrating Bioinformatic Knowledge
    Intervirology 55: 102-107, 2012
  14. Martin Obermeier, Ricardo Camacho, Charlotte Charpentier, Diane Deschamps, Joseph Eberle, Lutz Gürtler, Jean Ruelle, Alejandro Pironti, Francoise Brun-Veziet, Martin Stürmer, and Rolf Kaiser
    HIV2EU: supporting standardized HIV-2 drug resistance interpretation in Europe
    In: Journal of the International AIDS Society, Glasgow, UK, 2012, 135 p.
  15. Saleta Sierra, Jan Nikolaj Dzbowski, Alejandro Pironti, L Gueney, Alexander Thielen, Stefan Reuter, Stefan Esser, Gerd Fätkenheuer, Thomas Lengauer, Dominik Hider, Daniel Hoffmann, Holger Pfister, Björn Jensen, and Rolf Kaiser
    Optimisation of baseline genotypic testing for safe and efficient maraviroc administration
    In: Journal of the International AIDS Society, Glasgow, UK, 2012, 101-102
  16. Alejandro Pironti, André Altmann, Joachim Büch, and Thomas Lengauer
    A Computational Method for Predicting First-Line Antiretroviral Therapy Success
    In: Abstract Book. 9th Workshop on HIV & Hepatitis Treatment Strategies & Antiviral Drug Resistance, Paphos, Cyprus, 2011, 94 p.
  17. Alejandro Pironti
    Probabilistic disease gene prioritization
    Master's thesis, Universität des Saarlandes, 2009
  18. Andre Altmann, Alejandro Pironti, Juliane Perner, Joachim Büch, and Thomas Lengauer
    Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data
    In: Abstract Book. 8th European Drug Resistance Workshop, Sorrento, Italy, 2010, 46 p.